                </a></li></ul></div><p><strong>Figure 2.  <span>Whole-cell patch clamp recordings of mEPSCs in the parvocellular neurons of the PVN.</span></strong></p><a id="article1.body1.sec2.sec4.fig1.caption1.p1" name="article1.body1.sec2.sec4.fig1.caption1.p1"></a><p>Application of ghrelin (100 nM) in the extracellular solution decreased the amplitude and frequency of the mEPSCs (<a href="#pone-0001797-g002">Fig. 2A–C</a>). Extracellular administration of the cannabinoid receptor antagonist AM251 (1 µM), however, blocked the effect of ghrelin. Both amplitude and frequency changes were attenuated (<a href="#pone-0001797-g002">Fig. 2D–F</a>). In addition, intracellularly applied BAPTA, an effective chelator of free calcium, (<a href="#pone-0001797-g002">Fig. 2G–I</a>) and the DAG lipase (DAGL) inhibitor THL (5 µM) (<a href="#pone-0001797-g002">Fig. 2J–L</a>) also abolished the effect of ghrelin.</p>
